Susquehanna Fundamental Investments LLC Takes $503,000 Position in Omada Health, Inc. $OMDA

Susquehanna Fundamental Investments LLC acquired a new position in shares of Omada Health, Inc. (NASDAQ:OMDA) in the 2nd quarter, HoldingsChannel reports. The fund acquired 22,900 shares of the company’s stock, valued at approximately $503,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of OMDA. Raymond James Financial Inc. bought a new position in Omada Health in the 2nd quarter worth $32,000. Quarry LP bought a new stake in Omada Health during the fourth quarter valued at about $29,000. Versant Capital Management Inc grew its position in shares of Omada Health by 319.3% in the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares during the last quarter. Legal & General Group Plc acquired a new stake in shares of Omada Health in the second quarter valued at about $76,000. Finally, JPMorgan Chase & Co. bought a new position in shares of Omada Health in the third quarter worth about $82,000.

Wall Street Analyst Weigh In

Several analysts recently weighed in on OMDA shares. Robert W. Baird increased their target price on Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a research note on Wednesday, August 12th. Wells Fargo & Company lifted their price target on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Citigroup reissued an “outperform” rating on shares of Omada Health in a research report on Friday, August 14th. Needham & Company LLC reaffirmed a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. Finally, Citizens Jmp upped their target price on shares of Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research note on Friday, August 14th. Eleven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $26.50.

Insider Transactions at Omada Health

In other Omada Health news, CEO Sean P. Duffy sold 25,886 shares of Omada Health stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $22.68, for a total transaction of $587,094.48. Following the sale, the chief executive officer directly owned 411,861 shares of the company’s stock, valued at approximately $9,341,007.48. The trade was a 5.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Steven L. Cook sold 33,000 shares of the company’s stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $19.89, for a total value of $656,370.00. Following the completion of the sale, the chief financial officer owned 133,359 shares in the company, valued at approximately $2,652,510.51. This represents a 19.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 255,834 shares of company stock valued at $5,398,196. Corporate insiders own 6.38% of the company’s stock.

Omada Health Price Performance

Shares of Omada Health stock opened at $23.31 on Thursday. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The firm has a market capitalization of $1.43 billion, a PE ratio of 466.20 and a beta of 1.86. The company’s fifty day moving average price is $22.59 and its two-hundred day moving average price is $17.46.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.10. The business had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. Analysts predict that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.